Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia
Authors:
- Magdalena NiemiraMNMagdalena Niemira
- Jarosław DastychJDJarosław Dastych
- Zofia MazerskaZofia Mazerska
- 1 July 2013
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 86 (2) , 231-241
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cell-based systems to assess nuclear receptor activation and their use in drug developmentDrug Metabolism Reviews, 2013
- Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic responseCancer Letters, 2013
- Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transportersBiochemical Pharmacology, 2012
- Overcoming drug resistance by regulating nuclear receptorsAdvanced Drug Delivery Reviews, 2010
- PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell lineCancer Chemotherapy and Pharmacology, 2009
- Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activationJournal of Lipid Research, 2009
- Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cellsBMC Cancer, 2009
- Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alphaBMC Cancer, 2008
- Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cellsEndocrine-Related Cancer, 2007
- Comparative analysis of mutagenic potency of 1-nitro-acridine derivativesLife Sciences, 2005